跳至主要内容
临床试验/ITMCTR2000004186
ITMCTR2000004186招募中未知

A protocol of randomized controlled trial for Modified Xiaoyao Powder in the treatment of chronic obstructive pulmonary disease combined mild to moderate depression

Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • •1. Aged 18 to 65 years men and women;
  • •2. Patients who had received a diagnosis of COPD combined mild to moderate depression (HAMD-17 score 7 to 24) and meet the syndrome of stagnation of liver qi of depression;
  • •3. The course of depression does not exceed 3 months;
  • •4. The patients has not taken antidepressants in the past 1 month;
  • •5. Agree to participate and sign an informed consent form.

排除标准

  • •1. A history of a suicide attempt treament-resistant depression, and familial mental illness;
  • •2. Had a recent history of other acute or chronic significant clinical manifestations medical conditions;
  • •3. A history of bipolar disorder, schizophrenia, or schizo affective disorder;
  • •4. Patients who cannot actively cooperate with the treatment.

研究者

发起方
Hospital of Chengdu University of Traditional Chinese Medicine

相似试验